Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | SQLE | Q14534 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7590241 | 1.00 | KMT2A (0.42) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL474145 | 0.87 | KMT2A (0.43) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL118427 | 0.85 | KMT2A (0.46) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL120741 | 0.85 | KMT2A (0.42) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL120742 | 0.85 | KMT2A (0.42) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL10706181 | 0.85 | KMT2A (0.46) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL5857342 | 0.84 | KMT2A (0.44) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL121994 | 0.84 | KMT2A (0.41) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL5857338 | 0.84 | KMT2A (0.44) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL121342 | 0.84 | KMT2A (0.41) | KMT2AALOX15MEN1CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0813879-B1 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-10-30 | — | — | EP | claimed |
| CN-117396187-A | Composition for administration in a body cavity comprising cannabidiol | 融实医药(海南)有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117279623-A | Wound treatment composition | 融实医药(海南)有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-109641030-B | Methods and compositions for modulating opioid withdrawal symptoms | 优特埃合伙有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-113811306-A | Topical formulations for the treatment of peripheral neuropathy | 温桑托尔公司 | 2021-12-17 | — | — | CN | disclosed |
| EP-0813879-B1 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-10-30 | — | — | EP | disclosed |
| EP-0813879-A2 | Drug administration composition for iontophoresis | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 1997-12-29 | — | — | EP | disclosed |